Singapore Medication Assisted Therapy (MAT) Market to 2032
Overview
The Singapore Medication Assisted Therapy (MAT) Market is expected to reach a 216.97 by 2032 and is projected to grow at a CAGR of 13.44% from 2025 to 2032.
Revenue, 2024 ()
112.34
Forecast, 2032 ()
216.97
CAGR, 2024 - 2032
13.44%
Report Coverage
Singapore
Singapore Medication Assisted Therapy (MAT) Market 2018-2032
Singapore Medication Assisted Therapy (MAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 112.34
- Projected Market Size (2032): 216.97
- CAGR (2025-2032): 13.44%
Key Findings of Singapore Medication Assisted Therapy (MAT) Market
- The Singapore Medication Assisted Therapy (MAT) Market was valued at 112.34 in 2024.
- The Singapore Medication Assisted Therapy (MAT) Market is likely to grow at a CAGR of 13.44% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adults in Population Type Segment accounted for the largest share of the market with a revenue of 105.66
- The fastest growing segment Buprenorphine and Naloxone in Products Segment grew Fastest with a CAGR of 16.12% during the forecast period from 2024 to 2032.
Singapore Medication Assisted Therapy (MAT) Market Scope
Singapore Medication Assisted Therapy (MAT) Market Segmentation & Scope
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Route of Administration
- Others
- Parenteral
- Oral
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Dosage Form
- Extented Release
- Immediate Release
Type
- Therapy
- Medication
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Drug Type
- Branded
- Generics
Singapore Medication Assisted Therapy (MAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in |
| Market Value in 2024 | 112.34 |
| Market Value in 2032 | 216.97 |
| CAGR (2025-2032) | 13.44% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,Route of Administration,Population Type,End User,Dosage Form,Type,Products,Drug Type |
Regional Insights:
-
Leading Market (2024-2032): Singapore, leading in terms of revenue 112.34 in 2024
- Key Country: Singapore, leading in terms of revenue with value of 112.34 in 2024.
Segments and Scope
-
Singapore Medication Assisted Therapy (MAT) Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 32.90 in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 15.06 % in forecast period 2025-2032.
-
Singapore Medication Assisted Therapy (MAT) Market to 2032, By Route of Administration
- Oral is the largest segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 33.17 in the year 2024.
- Oral is the Fastest growing segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 15.02 % in forecast period 2025-2032.
-
Singapore Medication Assisted Therapy (MAT) Market to 2032, By Population Type
- Adults is the largest segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 105.66 in the year 2024.
- Adults is the Fastest growing segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 13.55 % in forecast period 2025-2032.
-
Singapore Medication Assisted Therapy (MAT) Market to 2032, By End User
- Rehabilitation Clinics is the largest segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 50.35 in the year 2024.
- Rehabilitation Clinics is the Fastest growing segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 14.58 % in forecast period 2025-2032.
-
Singapore Medication Assisted Therapy (MAT) Market to 2032, By Dosage Form
- Immediate Release is the largest segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 35.91 in the year 2024.
- Immediate Release is the Fastest growing segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 14.82 % in forecast period 2025-2032.
-
Singapore Medication Assisted Therapy (MAT) Market to 2032, By Type
- Medication is the largest segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 59.51 in the year 2024.
- Medication is the Fastest growing segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 14.23 % in forecast period 2025-2032.
-
Singapore Medication Assisted Therapy (MAT) Market to 2032, By Products
- Buprenorphine and Naloxone is the largest segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 14.25 in the year 2024.
- Buprenorphine and Naloxone is the Fastest growing segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 16.12 % in forecast period 2025-2032.
-
Singapore Medication Assisted Therapy (MAT) Market to 2032, By Drug Type
- Generics is the largest segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 54.84 in the year 2024.
- Generics is the Fastest growing segment in Singapore Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 14.39 % in forecast period 2025-2032.
Singapore Medication Assisted Therapy (MAT) Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Indivior PLC | |||
| Mallinckrodt | |||
| Sun Pharmaceutical Industries Ltd. | |||
| Teva Pharmaceutical Industries Ltd. | |||
Singapore Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032
Singapore Medication Assisted Therapy (MAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Singapore Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Distribution Channel,Route of Administration,Population Type,End User,Dosage Form,Type,Products,Drug Type.
Singapore Medication Assisted Therapy (MAT) Market was valued at USD 112.34(Revenue in ) in 2020.
Singapore Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 13.44% during the forecast period of 2024 to 2032.
The Adults segment is expected to dominate the Singapore Medication Assisted Therapy (MAT) Market, holding a largest market share of 105.66 in 2024
Coming Soon....
Singapore Medication Assisted Therapy (MAT) Market Scope
Singapore Medication Assisted Therapy (MAT) Market Segmentation & Scope
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Route of Administration
- Others
- Parenteral
- Oral
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Dosage Form
- Extented Release
- Immediate Release
Type
- Therapy
- Medication
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Drug Type
- Branded
- Generics
Frequently Asked Questions
The Singapore Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Distribution Channel,Route of Administration,Population Type,End User,Dosage Form,Type,Products,Drug Type.
Singapore Medication Assisted Therapy (MAT) Market was valued at USD 112.34(Revenue in ) in 2020.
Singapore Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 13.44% during the forecast period of 2024 to 2032.
The estimated market value of the Singapore Medication Assisted Therapy (MAT) Market for final year is USD 216.97 ().
Singapore Medication Assisted Therapy (MAT) Market Company Profiling
Frequently Asked Questions
The Singapore Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Distribution Channel,Route of Administration,Population Type,End User,Dosage Form,Type,Products,Drug Type.
Singapore Medication Assisted Therapy (MAT) Market was valued at USD 112.34(Revenue in ) in 2020.
Singapore Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 13.44% during the forecast period of 2024 to 2032.
The estimated market value of the Singapore Medication Assisted Therapy (MAT) Market for final year is USD 216.97 ().
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.